Pfizer Dodges Challenge to Its Board
Pfizer avoids board nominations from Starboard as proxy fight rolls on: Bloomberg
Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the activist investor’s unfolding proxy fight. | Activist Investor Starboard Value stopped short of nominating any directors to Pfizer’s board ahead of a Jan.
5don MSN
Average Cost: $70.92 Activist Commentary: Starboard is a very successful activist investor and has extensive experience ...
Bitcoin miner Riot Platforms (RIOT) finds itself a target of a second activist investor, with Reuters reporting investment ...
GlobalData on MSN10d
Starboard Value acquires 7.7% stake in chipmaker QorvoActivist investor Starboard Value has acquired a 7.7% stake in Qorvo, a NASDAQ-listed maker of radio frequency and power ...
D.E. Shaw’s stake in Riot Platforms, alongside Starboard’s involvement, signals potential changes for the Bitcoin mining giant.
Investment firm D.E. Shaw has built a position in Riot Platforms and may push it to make changes, two sources familiar with ...
Starboard last year took a $1 billion stake in Pfizer, looking to turn the pharma around after alleged severe shortcomings by ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Activist Investor Starboard Value Takes 7.7% Stake in Chipmaker Qorvo (Reuters) -Starboard Value has built a 7.7% stake in Qorvo, the chipmaker revealed in a filing on Friday, as the activist ...
Pavlo Gonchar / SOPA Images / LightRocket via Getty Images Qorvo shares jumped 11% Friday when hedge fund Starboard Value made a significant investment in the maker of radio frequency and power ...
Qorvo (QRVO) shares fell 0.5% in premarket trading on Friday, even as Mizuho Securities upped its earnings estimates on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback